The Pharmacy Industry in Stange: Current Situation and Future Prospects

The pharmacy industry in Stange has shown both strength and uncertainty in recent years. With three registered companies and a mix of stable and fluctuating financial results, the industry is characterized by large variations in sales and number of employees. There are no registered bankruptcies in the sector, which indicates a certain level of stability. Nevertheless, data shows a very dynamic development, with both strong increases and decreases in sales and employees over time. This may be due to both local conditions and broader market developments.

Sales and employees in the pharmacy industry in Stange have shown large variations in recent years. Sales had a strong increase from 2017 to 2018 (+234.1%), but fell by 32.0% from 2020 to 2021 and continued with a decline of 19.6% from 2024 to 2025. The number of employees increased from 2016 to 2019, before a sharp decline from 2020 to 2021 (-38.9%). There is a weak increase in the number of employees from 2025 to 2026 (+50.0%), which may indicate an emerging stabilization. EBITDA margins are at 7% for Stange and 1% for Ottestad, showing that Stange has better profitability in the industry.

In Stange, three companies are registered in the pharmacy industry:

All companies have the organizational form AS, which is common for larger companies in Norway. There are no registered bankruptcies among these companies, indicating a certain level of financial stability. Apotek 1 Stange has the highest sales and EBITDA, while Boots Apotek Stange Bruk shows zero sales and EBITDA, which may indicate a temporary downturn or specific circumstances.

Pharmacy activity in Stange is distributed across two areas:

Stange has twice as many companies as Ottestad, and there is a clear difference in sales and operating income. Stange also has a higher EBITDA margin (7%) compared to Ottestad (1%). This suggests that Stange has better profitability in the pharmacy industry, even though Ottestad has a higher gross profit percentage (8914%) compared to Stange (38592%).

The industry has proven to be relatively stable with no registered bankruptcies. Nevertheless, data shows large variations in sales and employees over time. The strongest sales increase occurred from 2017 to 2018 (+234.1%), which may be due to specific market conditions or expansion. Subsequently, sales and employees have shown a more unstable development, with a sharp decline from 2020 to 2021. This may indicate the influence of external factors such as the pandemic or changes in consumer behavior. There is a weak increase in the number of employees from 2025 to 2026, which may be a sign of an emerging stabilization.

For entrepreneurs considering establishing themselves in the pharmacy industry in Stange, data shows both opportunities and challenges. The high gross profit (up to 38,592%) and relatively stable EBITDA margins (7%) indicate potential for profitability. Nevertheless, it is important to be aware of the large variations in sales and employees over time, which can be influenced by both local and national factors. Ottestad shows potential for development with high gross profit, even though sales and operating income are lower than in Stange. SmartGrunder can help entrepreneurs find suitable addresses in Stange for pharmacy activities, with a focus on natural conditions and market prospects.

The pharmacy industry in Stange has proven to be both dynamic and challenging. With three companies and a mix of stable and fluctuating financial results, the industry is characterized by variations in sales and employees. There are no bankruptcies, which indicates a certain level of stability. Nevertheless, data shows large variations over time, which can be influenced by both local and national factors. For entrepreneurs, it is important to assess both the opportunities in the industry and the potential challenges, which may include market fluctuations and variations in operating income. SmartGrunder can help find suitable addresses in Stange for pharmacy activities, with a focus on natural conditions and market prospects.